What happened
ABL Bio disclosed an acquisition of NEOK Bio, Inc., worth US$24.9M.
For context, this deal is worth about 12.9% of the company's own total assets.
| Target | NEOK Bio, Inc. |
|---|---|
| Deal value | US$24.9M |
| vs. company assets | 12.9% |
| Filed | 2026-03-30, Decision to acquire shares/equity in another company |
| Source | DART rcept 20260330901437 → open original filing |
Source: DART. Information only, not investment advice.